Pediatrics

Rashtriya Bal Swasthya Karyakram (RBSK) — The “4 D’s” Screening Framework

A comprehensive child health screening and early intervention program targeting children from birth to 18 years, delivered through dedicated Mobile Health Teams at Anganwadi centers and schools.

Children identified through RBSK screening receive free treatment and management via the linked referral system, including tertiary-level intervention (e.g., cardiac surgery for identified CHD).

POSHAN Abhiyaan

India's National Nutrition Mission — improves nutritional outcomes for children, adolescent girls, pregnant women, and lactating mothers via a convergent, multi-sectoral approach.

• Improved service delivery through convergence of existing nutrition schemes/programs
• Use of technology for real-time monitoring of nutritional indicators
• Intensified IEC (Information, Education, Communication) activities promoting appropriate nutrition/feeding practices
• Specific, measurable targets for reducing stunting, wasting, underweight prevalence, and anemia

India Newborn Action Plan (INAP)

India's targeted strategic framework aimed at reducing preventable newborn mortality and stillbirths, aligned with the global Every Newborn Action Plan. Establishes specific numerical targets for reducing NMR and stillbirth rate.

Strategic pillars:

1. Strengthening quality of care around the time of birth (NRP/delivery room resuscitation principles)
2. Strengthening small and sick newborn care services (special newborn care units and related infrastructure)
3. Strengthening community-based newborn care and family/community engagement

Current Trends in IMR and NMR in India

India has shown sustained decline in IMR and NMR. However, an important, frequently-tested point: the relative contribution of the neonatal period to overall under-5 mortality has progressively increased, as post-neonatal/older childhood mortality (diarrhea, pneumonia) has declined more substantially than neonatal mortality.

SDG 3.2 Targets

SDG 3 (Good Health and Well-being), Target 3.2: “End preventable deaths of newborns and children under 5 years of age.”

Evidence-Based Interventions to Reduce Child Mortality

• Perinatal/neonatal care — skilled birth attendance, essential newborn care, NRP-based resuscitation, Kangaroo Mother Care, management of sepsis/asphyxia/prematurity complications
• Nutrition — exclusive breastfeeding promotion, appropriate complementary feeding, SAM management (WHO 10-step protocol)
• Immunization — per the National Immunization Schedule
• Case management of major childhood killers — diarrheal disease (ORS + zinc), pneumonia (antibiotics; IMNCI algorithm-based identification)
• Broader determinants — water/sanitation/hygiene, maternal education, poverty reduction

Steps in Conducting a Systematic Review

1. Formulate a clear, focused research question (commonly structured using the PICO framework — Population, Intervention, Comparison, Outcome)
2. Develop and, ideally, prospectively register a detailed study protocol
3. Conduct a comprehensive, systematic literature search across multiple databases
4. Screen identified studies against pre-specified inclusion/exclusion criteria (independently by ≥2 reviewers)
5. Extract data using a standardized extraction form
6. Assess methodological quality/risk of bias using a validated tool
7. Perform meta-analysis (quantitative statistical synthesis), where studies are sufficiently similar

PRISMA Guidelines

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) provides a standardized reporting checklist and flow diagram documenting: records identified, number screened, number excluded at each stage (with reasons), and final number included in qualitative/quantitative synthesis.

Forest Plot Interpretation

Each horizontal line = one study's point estimate (square, sized by weight) with 95% CI. The vertical “line of no effect” sits at 1.0 (ratio measures) or 0 (difference measures). The pooled/summary estimate is shown as a diamond at the bottom; if its CI does not cross the line of no effect, the pooled result is statistically significant.

Heterogeneity — I²

High heterogeneity prompts subgroup analysis, meta-regression, or a shift from fixed-effect to random-effects model.

Publication Bias — Funnel Plot

Plots each study's effect estimate (x-axis) against precision/standard error (y-axis). Symmetric inverted-funnel shape expected in the absence of bias; asymmetry (missing small negative studies) suggests publication bias and possible overestimation of true effect.

Choosing Appropriate Statistical Tests

Non-parametric tests use ranks rather than raw values, making them more robust to non-normal distributions/outliers or small sample sizes where normality cannot be assumed.

Concept of p-value

The probability of observing a result as extreme as, or more extreme than, the one observed, assuming the null hypothesis is true. A conventionally small p-value (<0.05) provides evidence against the null hypothesis.

Confidence Intervals

A 95% CI provides the range within which the true population parameter is expected to lie with 95% confidence. Conveys both precision (narrower = more precise, larger sample) and the magnitude/plausible range of effect — information a p-value alone does not provide.

For RR/OR, a 95% CI that does not cross 1.0 corresponds to statistical significance at p<0.05.

Four Core Bioethical Principles

Informed Consent from Parents and the Assent Process in Children

ICMR Guidelines

India's ICMR provides national ethical guidelines for research involving children, addressing the parental consent/child assent framework and a risk categorization system:

1. Minimal risk research
2. Greater than minimal risk with prospect of direct benefit to the individual child
3. Greater than minimal risk without direct prospect of benefit — requires the most rigorous additional ethical justification and safeguards

Ethics Committee Review

All research involving human participants requires prospective review and approval by an Institutional Ethics Committee (IEC) before commencement — reviewing scientific validity, ethical acceptability, consent/assent adequacy, risk-benefit balance, and ongoing monitoring.

Principles of IMNCI

A structured, algorithm-based clinical assessment and management strategy (WHO/UNICEF) for frontline health workers in resource-limited settings. Rationale: sick children often present with overlapping, non-specific symptoms — a single-disease-focused approach risks missing serious co-existing conditions. IMNCI uses a holistic, integrated assessment via a standardized algorithm usable by modestly-trained health workers.

Color-Coded Triage System

For infants 0–2 months (Sick Young Infant)

Specifically-tailored assessment reflecting young infants' distinct disease presentation and heightened vulnerability, with particular emphasis on recognizing signs of possible serious bacterial infection. Uses a similar color-coded structure to guide urgent referral vs outpatient management.

For children 2 months to 5 years

Systematically assesses: cough/difficulty breathing (pneumonia), diarrhea (dehydration/persistent/dysenteric patterns), fever (malaria in endemic areas, measles, other causes), ear problems, and nutritional/growth status and anemia.

Next-Generation Sequencing (NGS)

Massively parallel sequencing of millions of DNA fragments simultaneously — contrasted with older Sanger sequencing (targeted, one region at a time; still used for confirming a specific suspected mutation). NGS has dramatically reduced cost/time of large-scale genomic sequencing.

Whole Exome Sequencing (WES) vs Whole Genome Sequencing (WGS)

Chromosomal Microarray (CMA)

Detects copy number variants (deletions/duplications) at higher resolution than karyotyping — recommended first-tier test for unexplained developmental delay/intellectual disability and multiple congenital anomalies.

Gene Editing — CRISPR-Cas9

Uses a bacterial-derived Cas9 endonuclease, guided by a designed guide RNA complementary to the target DNA, to create a precise double-strand break at a desired genomic location. Repaired via:

• Non-homologous end joining (NHEJ) — error-prone; used to disrupt/“knock out” a gene (e.g., disrupting a repressor to reactivate fetal hemoglobin in thalassemia/sickle cell gene therapy)
• Homology-directed repair (HDR) — uses a DNA template for precise sequence correction; less efficient/more technically challenging

Clinical application already realized in pediatric hematology (exagamglogene autotemcel/Casgevy for thalassemia/sickle cell disease).

The 10 Warning Signs of PIDD

(Jeffrey Modell Foundation, adapted by national/international immunodeficiency organizations)

1. ≥4 new ear infections within 1 year
2. ≥2 serious sinus infections within 1 year
3. ≥2 months on antibiotics with little effect
4. ≥2 pneumonias within 1 year
5. Failure of an infant to gain weight or grow normally
6. Recurrent, deep skin or organ abscesses
7. Persistent thrush in the mouth or fungal infection on the skin, after age 1
8. Need for IV antibiotics to clear infections
9. ≥2 deep-seated infections, including septicemia
10. A family history of PIDD

Diagnostic Algorithm by Immune Component